Capital Analysts LLC’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-816
Closed -$8K 1184
2023
Q2
$8K Sell
816
-2,463
-75% -$20.8K ﹤0.01% 844
2023
Q1
$27K Sell
3,279
-29
-0.9% -$320 ﹤0.01% 680
2022
Q4
$37K Buy
3,308
+69
+2% +$802 ﹤0.01% 669
2022
Q3
$38K Buy
3,239
+32
+1% +$485 ﹤0.01% 616
2022
Q2
$49K Buy
3,207
+384
+14% +$6.91K ﹤0.01% 564
2022
Q1
$60K Sell
2,823
-661
-19% -$14.2K ﹤0.01% 524
2021
Q4
$82K Buy
3,484
+189
+6% +$4.05K 0.01% 483
2021
Q3
$66K Buy
3,295
+711
+28% +$14.6K ﹤0.01% 540
2021
Q2
$52K Buy
2,584
+137
+6% +$2.93K ﹤0.01% 556
2021
Q1
$52K Buy
+2,447
New +$52.6K ﹤0.01% 584

Other funds holding MPT

Capital Analysts LLC's MPT Position: Q3 2023 in Review

Capital Analysts LLC sold out of Medical Properties Trust (MPT) in Q3 2023, closing a stake of 816 shares — an estimated $8K sold.

Capital Analysts LLC first reported a position in MPT in Q1 2021 and held it in 10 quarters. The position peaked at $82K in Q4 2021. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • Capital Analysts LLC reported no remaining Medical Properties Trust position as of Q3 2023 after selling out during the quarter.
  • Capital Analysts LLC sold 816 Medical Properties Trust shares in Q3 2023, an estimated $8K.
  • Capital Analysts LLC first reported a position in Medical Properties Trust in Q1 2021 and held it in 10 quarters.
  • Capital Analysts LLC's Medical Properties Trust position peaked at $82K in Q4 2021.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on Capital Analysts LLC's 13F filing for Q3 2023, filed 13 Nov 2023.